Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS.
Signaling adaptor protein Crk regulates cell motility and growth through its targets Dock180 and C3G, those are the guanine-nucleotide exchange factors (GEFs) for small GTPases Rac and Rap, respectively. Recently, overexpression of Crk has been reported in various human cancers. To define the role for Crk in human cancer cells, Crk expression was targeted in the human ovarian cancer cell line MCAS through RNA interference, resulting in the establishment of three Crk knockdown cell lines. These cell lines exhibited disorganized actin fibers, reduced number of focal adhesions, and abolishment of lamellipodia formation. Decreased Rac activity was demonstrated by pull-down assay and FRET-based time-lapse microscopy, in association with suppression of both motility and invasion by phagokinetic track assay and transwell assay in these cells. Furthermore, Crk knockdown cells exhibited slow growth rates in culture and suppressed anchorage-dependent growth in soft agar. Tumor forming potential in nude mice was attenuated, and intraperitoneal dissemination was not observed when Crk knockdown cells were injected into the peritoneal cavity. These results suggest that the Crk is a key component of focal adhesion and involved in cell growth, invasion, and dissemination of human ovarian cancer cell line MCAS.
Laboratory of Molecular and Cellular Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
H
H
Linghu
M
M
Tsuda
Y
Y
Makino
M
M
Sakai
T
T
Watanabe
S
S
Ichihara
H
H
Sawa
K
K
Nagashima
N
N
Mochizuki
S
S
Tanaka
D008841:Actin Cytoskeleton / Q000473:pathology; D000818:Animals; D002448:Cell Adhesion / Q000502:physiology; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D015151:Immunoblotting; D051379:Mice; D008819:Mice, Nude; D009361:Neoplasm Invasiveness; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000473:pathology; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000473:pathology; D050737:Proto-Oncogene Proteins c-crk / Q000378:metabolism*; D011554:Pseudopodia / Q000473:pathology; D034622:RNA Interference; D020744:rac GTP-Binding Proteins / Q000378:metabolism
C485285:CRK protein, human; D050737:Proto-Oncogene Proteins c-crk; D020744:rac GTP-Binding Proteins